Objective The aim of this study was to determine the prevalence of cognitive impairment (CI)
in newly diagnosed and orchiectomized testicular cancer (TC) patients prior to systemic …

Purpose The aim of the present study was to determine the prevalence of cognitive
impairment (CI) in a group of testicular (TC) survivors by comparing their neuropsychological …

OBJECTIVE: There is a concern about negative cognitive effects of systemic chemotherapy.
We prospectively explored self-reported cognitive problems in testicular cancer patients …

BACKGROUND: Cognitive dysfunction experienced by individuals with cancer represents
an important survivorship issue because of its potential to affect occupational, scholastic …

Cancer patients frequently report cognitive complaints following chemotherapy, but the
results from the available studies, mainly of women with breast cancer, are inconsistent. Our …

Objective: To study the level of cancer‐related distress (CRD) and variables associated with
CRD in recently diagnosed testicular cancer patients (TCPs), and to explore associations …

Background Treatment for cancer may lead to development of cognitive difficulties in cancer
survivors. This study aimed to evaluate long‐term cognitive functioning (CogF) in germ‐cell …

Background Whether systemic chemotherapy has a negative effect on cognitive function in
patients, concern oncologists. In testicular cancer patients (TCPs) treated with cisplatin …

Evidence suggests that testicular cancer (TC) and its treatment are associated with cognitive
impairment. However, the underlying neural substrate and biological mechanisms are …

Purpose The causal link between chemotherapy and cognitive impairment is unclear. We
studied testicular cancer patients' objective and subjective cognitive function longitudinally …